| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9643719 | Journal of the American Academy of Child & Adolescent Psychiatry | 2005 | 6 Pages |
Abstract
This open-label study found escitalopram to be useful in treating some difficulties common in PDDs. A wide variability in dose was found that could not be accounted for by weight and only partially by age. The study provides information useful for the design of double-blind, placebo-controlled studies of escitalopram in PDDs.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
THOMAS M.D., LAURA R.N., M.Ed, JEFF D.CLIN.PSY., STEPHEN J. M.A., MARREA PH.D., BENNETT L. M.D., EDWIN H. M.D.,